Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
Research Article

Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1

Alison L. Hill, View ORCID ProfileDaniel I. S. Rosenbloom, Feng Fu, Martin A. Nowak, and Robert F. Siliciano
  1. aProgram for Evolutionary Dynamics, Department of Mathematics, and Department of Organismic and Evolutionary Biology, and
  2. bBiophysics Program and Harvard-MIT Division of Health Sciences and Technology, Harvard University, Cambridge, MA 02138;
  3. cDepartment of Biomedical Informatics, Columbia University Medical Center, New York, NY 10032;
  4. dInstitute of Integrative Biology, Eidgenössische Technische Hochschule Zürich, 8092 Zurich, Switzerland; and
  5. eDepartment of Medicine and
  6. fHoward Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21205

See allHide authors and affiliations

PNAS September 16, 2014 111 (37) 13475-13480; first published August 5, 2014; https://doi.org/10.1073/pnas.1406663111
Alison L. Hill
aProgram for Evolutionary Dynamics, Department of Mathematics, and Department of Organismic and Evolutionary Biology, and
bBiophysics Program and Harvard-MIT Division of Health Sciences and Technology, Harvard University, Cambridge, MA 02138;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: alhill@fas.harvard.edu
Daniel I. S. Rosenbloom
aProgram for Evolutionary Dynamics, Department of Mathematics, and Department of Organismic and Evolutionary Biology, and
cDepartment of Biomedical Informatics, Columbia University Medical Center, New York, NY 10032;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel I. S. Rosenbloom
Feng Fu
dInstitute of Integrative Biology, Eidgenössische Technische Hochschule Zürich, 8092 Zurich, Switzerland; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin A. Nowak
aProgram for Evolutionary Dynamics, Department of Mathematics, and Department of Organismic and Evolutionary Biology, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert F. Siliciano
eDepartment of Medicine and
fHoward Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21205
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  1. Edited by John M. Coffin, Tufts University School of Medicine, Boston, MA, and approved July 9, 2014 (received for review April 12, 2014)

  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

Significance

HIV infection cannot be cured by current antiretroviral drugs, due to the presence of long-lived latently infected cells. New antilatency drugs are being tested in clinical trials, but major unknowns remain. It is unclear how much latent virus must be eliminated for a cure, which remains difficult to answer empirically due to few case studies and limited sensitivity of viral reservoir assays. In this paper, we introduce a mathematical model of HIV dynamics to calculate the likelihood and timing of viral rebound following antilatency treatment. We derive predictions for the required efficacy of antilatency drugs, and demonstrate that rebound times may be highly variable and occur after years of remission. These results will aid in designing and interpreting HIV cure studies.

Abstract

Massive research efforts are now underway to develop a cure for HIV infection, allowing patients to discontinue lifelong combination antiretroviral therapy (ART). New latency-reversing agents (LRAs) may be able to purge the persistent reservoir of latent virus in resting memory CD4+ T cells, but the degree of reservoir reduction needed for cure remains unknown. Here we use a stochastic model of infection dynamics to estimate the efficacy of LRA needed to prevent viral rebound after ART interruption. We incorporate clinical data to estimate population-level parameter distributions and outcomes. Our findings suggest that ∼2,000-fold reductions are required to permit a majority of patients to interrupt ART for 1 y without rebound and that rebound may occur suddenly after multiple years. Greater than 10,000-fold reductions may be required to prevent rebound altogether. Our results predict large variation in rebound times following LRA therapy, which will complicate clinical management. This model provides benchmarks for moving LRAs from the laboratory to the clinic and can aid in the design and interpretation of clinical trials. These results also apply to other interventions to reduce the latent reservoir and can explain the observed return of viremia after months of apparent cure in recent bone marrow transplant recipients and an immediately-treated neonate.

  • HIV latent reservoir
  • HIV cure
  • viral dynamics

Footnotes

  • ↵1A.L.H. and D.I.S.R. contributed equally to this work.

  • ↵2To whom correspondence should be addressed. Email: alhill{at}fas.harvard.edu.
  • Author contributions: A.L.H., D.I.S.R., M.A.N., and R.F.S. designed research; A.L.H., D.I.S.R., and F.F. performed research; A.L.H., D.I.S.R., and F.F. contributed new analytic tools; A.L.H. and D.I.S.R. analyzed data; and A.L.H., D.I.S.R., M.A.N., and R.F.S. wrote the paper.

  • The authors declare no conflict of interest.

  • This article is a PNAS Direct Submission.

  • See Commentary on page 13251.

  • This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1406663111/-/DCSupplemental.

View Full Text
PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Modeling HIV antilatency drugs
Alison L. Hill, Daniel I. S. Rosenbloom, Feng Fu, Martin A. Nowak, Robert F. Siliciano
Proceedings of the National Academy of Sciences Sep 2014, 111 (37) 13475-13480; DOI: 10.1073/pnas.1406663111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Modeling HIV antilatency drugs
Alison L. Hill, Daniel I. S. Rosenbloom, Feng Fu, Martin A. Nowak, Robert F. Siliciano
Proceedings of the National Academy of Sciences Sep 2014, 111 (37) 13475-13480; DOI: 10.1073/pnas.1406663111
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley

Article Classifications

  • Biological Sciences
  • Medical Sciences
  • Physical Sciences
  • Applied Mathematics

See related content:

  • Stochastic noise affects HIV eradication
    - Sep 08, 2014
Proceedings of the National Academy of Sciences: 111 (37)
Table of Contents

Submit

Sign up for Article Alerts

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Materials and Methods
    • Acknowledgments
    • Footnotes
    • References
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Water from a faucet fills a glass.
News Feature: How “forever chemicals” might impair the immune system
Researchers are exploring whether these ubiquitous fluorinated molecules might worsen infections or hamper vaccine effectiveness.
Image credit: Shutterstock/Dmitry Naumov.
Reflection of clouds in the still waters of Mono Lake in California.
Inner Workings: Making headway with the mysteries of life’s origins
Recent experiments and simulations are starting to answer some fundamental questions about how life came to be.
Image credit: Shutterstock/Radoslaw Lecyk.
Cave in coastal Kenya with tree growing in the middle.
Journal Club: Small, sharp blades mark shift from Middle to Later Stone Age in coastal Kenya
Archaeologists have long tried to define the transition between the two time periods.
Image credit: Ceri Shipton.
Illustration of groups of people chatting
Exploring the length of human conversations
Adam Mastroianni and Daniel Gilbert explore why conversations almost never end when people want them to.
Listen
Past PodcastsSubscribe
Panda bear hanging in a tree
How horse manure helps giant pandas tolerate cold
A study finds that giant pandas roll in horse manure to increase their cold tolerance.
Image credit: Fuwen Wei.

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Cozzarelli Prize
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490